COVID-19 treatment: Roche, Cipla launch antibody cocktail Casirivimab and Imdevimab in India

COVID-19 treatment: Roche, Cipla launch antibody cocktail Casirivimab and Imdevimab in India The price for each patient dose [a combined dose of 1200 mg (600 mg of Casirivimab and 600 mg of Imdevimab) will be Rs 59,750 inclusive of all taxes.

No comments:

Post a Comment